NCT05860699View on ClinicalTrials.gov

Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH

PHASE2RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

May 23, 2026

Study Completion Date

May 23, 2026

Conditions
Severe Alcohol Use Disorder (DSM 5)
Interventions
DRUG

Placebo

Placebo made by the same manufacturer to look like the active pills

DRUG

Half dose CBD

add-on cannabidiol (Echo Pharmaceutical, BV) 450 mg per day for 10 days during their inpatient stay

DRUG

Full dose CBD

add-on cannabidiol (Echo Pharmaceutical, BV) 900 mg per day for 10 days during their inpatient stay

Trial Locations (1)

France

RECRUITING

Hôpital Fernand Widal, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER